Vimarsana
Biggest News Aggregation in the World

Page 18 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

MEI Pharma (NASDAQ:MEIP) Stock Price Crosses Below 200-Day Moving Average of $6.02 - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Stock Price Crosses Below 200-Day Moving Average of $6.02

MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.02 and traded as low as $4.25. MEI Pharma shares last traded at $4.26, with a volume of 17,436 shares trading hands. Analysts Set New Price Targets A […]

States Guard Drug Discount Program as Pharma Wages Legal Battles - Vimarsana News

States Guard Drug Discount Program as Pharma Wages Legal Battles

State legislation aiming to block discriminatory practices used against pharmacies in a federal drug discount program is ramping up this year despite legal challenges from the drug industry.

FSD Pharma Announces Debt Settlement - Vimarsana News

FSD Pharma Announces Debt Settlement

FSD Pharma Announces Debt Settlement

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model -February 28, 2024 at 01:01 pm EST - Vimarsana News

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model -February 28, 2024 at 01:01 pm EST

IGC Pharma, Inc. today announced the results of preclinical studies investigating its drug candidate TGR-63 as a treatment for Alzheimer's disease. The data demonstrated enhanced memory function in...

IGC Stock Price | IGC Pharma Inc. Stock Quote (U.S.: NYSE American) - Vimarsana News

IGC Stock Price | IGC Pharma Inc. Stock Quote (U.S.: NYSE American)

IGC | Complete IGC Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.